NCT06425029 Self-administered ONe-of-a Kind Approach to Epilepsy Therapy Through a Web-based Music Application
| NCT ID | NCT06425029 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Dartmouth-Hitchcock Medical Center |
| Condition | Epilepsy |
| Study Type | INTERVENTIONAL |
| Enrollment | 24 participants |
| Start Date | 2025-07-22 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 24 participants in total. It began in 2025-07-22 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a prospective, placebo-controlled, double-blinded randomized study of self-administered auditory intervention in a naturalistic home environment.
Eligibility Criteria
Inclusion Criteria: * Adults with medication-refractory focal epilepsy who have undergone RNS implantation at least six months prior and are in the judgement of the treating physician on a stable RNS regimen in terms of stimulation * Willing to attend all study visits and complete all required study procedures * Access to private or public wireless data service at regular intervals * Access to personal mobile device Exclusion Criteria: * Documentation of a musicogenic, or auditory-triggered focal seizure semiology * Participant is unable to reasonably participate in study tasks as determined by the investigator * Inability to obtain informed consent from the patient or legally authorized representative
Contact & Investigator
Brian C Fidali, MD
PRINCIPAL INVESTIGATOR
Dartmouth-Hitchcock Medical Center
Frequently Asked Questions
Who can join the NCT06425029 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Epilepsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06425029 currently recruiting?
Yes, NCT06425029 is actively recruiting participants. Contact the research team at Anastasia.Kanishcheva@Hitchcock.ORG for enrollment information.
Where is the NCT06425029 trial being conducted?
This trial is being conducted at Worcester, United States, Lebanon, United States.
Who is sponsoring the NCT06425029 clinical trial?
NCT06425029 is sponsored by Dartmouth-Hitchcock Medical Center. The principal investigator is Brian C Fidali, MD at Dartmouth-Hitchcock Medical Center. The trial plans to enroll 24 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.